<DOC>
	<DOCNO>NCT02837198</DOCNO>
	<brief_summary>To investigate pharmacodynamics , pharmacokinetics safety 7-day-repeated dos FYU-981 administer orally male hyperuricemic patient uric acid-overproduction uric acid-underexcretion type . In addition , investigate additive effect combination FYU-981 topiroxostat administer orally male hyperuricemic patient uric acid-overproduction type .</brief_summary>
	<brief_title>Study FYU-981 Hyperuricemia ( Effect Two Hyperuricemic Types )</brief_title>
	<detailed_description />
	<mesh_term>Hyperuricemia</mesh_term>
	<mesh_term>Uric Acid</mesh_term>
	<criteria>Japanese adult subject Serum urate level : &gt; = 7.0mg/dL patient Disease Type : Uric acidoverproduction Type Uric acidunderexcretion Type Gouty arthritis within year start study treatment Mixed type classification hyperuricemia</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>